Spinal cord injury (SCI), for which there currently is no cure, is a heavy burden on patient
physiology and psychology. The microenvironment of the injured spinal cord is complicated …

Neurotrophins are a family of proteins that regulate neuronal survival, synaptic function, and
neurotransmitter release, and elicit the plasticity and growth of axons within the adult central …

Stem cell therapies are being explored extensively as treatments for degenerative eye
disease, either for replacing lost neurons, restoring neural circuits or, based on more recent …

The incidence of acute and chronic spinal cord injury (SCI) in the United States is more than
10,000 per year, resulting in 720 cases per million persons enduring permanent disability …

Despite the vast improvements of cell therapy in spinal cord injury treatment, no optimum
protocol has been developed for application of neural stem/progenitor cells. In this regard …

Neural stem cells (NSCs) from embryonic or fetal/adult tissue sources have shown
considerable promise in regenerative strategies for traumatic spinal cord injury (SCI) …

Most studies targeting chronic spinal cord injury (SCI) have concluded that neural
stem/progenitor cell (NS/PC) transplantation exerts only a subclinical recovery; this in …

A variety of neurotrophic factors have been used in attempts to improve morphological and
behavioural outcomes after experimental spinal cord injury (SCI). Here we review many of …

The application of neurotrophic factors as a therapy to improve morphological and
behavioral outcomes after experimental spinal cord injury (SCI) has been the focus of many …

Acute spinal cord injury (SCI) is a devastating condition that results in tremendous physical
and psychological harm and a series of socioeconomic problems. Although neurons in the …